Prognostic understanding, quality of life (QOL), and mood in patients undergoing hematopoietic stem cell transplantation (HCT).

Authors

null

Areej El-Jawahri

Massachusetts General Hospital, Boston, MA

Areej El-Jawahri, Lara Traeger, Justin Eusebio, Kailyn Kuzmuk, Harry Vandusen, Jennifer Shin, Emily R. Gallagher, Joseph A. Greer, William F. Pirl, Karen K. Ballen, Thomas R. Spitzer, Timothy A. Graubert, Steven L. McAfee, Bimalangshu Dey, Vicki A. Jackson, Yi-Bin Albert Chen, Jennifer S. Temel

Organizations

Massachusetts General Hospital, Boston, MA, Massachusetts General Hospital Cancer Center, Boston, MA, Massachusetts General Hospital, Harvard Medical School, Boston, MA

Research Funding

No funding sources reported

Background: In advanced cancers, patients’ prognostic perceptions influence their medical decisions. However, little is known about how patients with hematologic malignancies undergoing HCT and their family caregivers (FC) understand their prognosis. We examined prognostic perception in these patients during hospitalization for HCT and its relationship with QOL and mood. Methods: We conducted a longitudinal study of patients (and FC) hospitalized for HCT. At baseline (6 days pre-HCT), we used a 10-item questionnaire to measure patients’ and FC information preferences, and perception of prognosis. Using 2-items, we also asked oncologists regarding the patients’ prognosis. At day-6, day+1, day+8 of HCT, we assessed QOL (Functional Assessment of Cancer Therapy-Bone Marrow Transplantation FACT-BMT), and mood (Hospital Anxiety and Depression Scale). We examined the relationship between patients’ prognostic perception and their QOL and mood during hospitalization for HCT using multivariable linear mixed models. Results: We enrolled 97% of consecutively eligible patients undergoing autologous (n=30), myeloablative (n=30) or reduced intensity (n=30) allogeneic HCT. Most patients (80/90, 88.9%) and FC (41/47, 87.1%) believed that it is ‘extremely’ or ‘very’ important to know about prognosis. However, the majority of patients (66/85, 77.6%) and FC (33/46, 71.7%) reported an inaccurate and more optimistic perception of the patients’ prognosis compared to the oncologist (P < 0.0001). Patients with accurate prognostic understanding reported lower QOL (P = 0.03) and worse depressive symptoms (P = 0.04) with a steeper increase in depression (P = 0.006) over time compared to patients with an inaccurate optimistic prognostic perception. Conclusions: The majority of patients and FC reported inaccurate and more optimistic perception of prognosis compared with the oncologist. Patients with an accurate perception of their prognosis had lower QOL, higher depression, and a steeper increase in depression during hospitalization for HCT. Interventions are needed to improve prognostic understanding while providing adequate psychosocial support during HCT.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Abstract Details

Meeting

2014 Palliative and Supportive Care in Oncology Symposium

Session Type

Poster Session

Session Title

General Poster Session B: <span>Early Integration of Palliative Care in Cancer Care, Patient-Reported Outcomes, and Psycho-Oncology</span>

Track

Early Integration of Palliative Care in Cancer Care,Patient-Reported Outcomes: Mechanisms of Symptoms and Treatment Toxicities,Psycho-oncology,End-of-Life Care,Survivorship

Sub Track

Psycho-oncology

Citation

J Clin Oncol 32, 2014 (suppl 31; abstr 219)

DOI

10.1200/jco.2014.32.31_suppl.219

Abstract #

219

Poster Bd #

F10

Abstract Disclosures

Similar Abstracts

First Author: Areej El-Jawahri

Abstract

2014 Palliative and Supportive Care in Oncology Symposium

Patients' and family caregivers' (FC) quality of life (QOL) and mood during hospitalization for hematopoietic stem cell transplantation (HCT).

First Author: Areej El-Jawahri